SEC Form 4 · accession 0001179110-16-027831
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendy E Rieder
Officer — Former SVP, Gen. Counsel
Period of report
Jul 22, 2016
Accepted (ET)
Jul 22, 2016 · 5:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 22, 2016 | A | 25,714 | $0.00 | A | 26,280 | D | |
| Common StockF3,F2 | Jul 22, 2016 | F | 8,550 | $9.48 | D | 17,730 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the vesting and settlement of restricted stock units ("RSUs") upon the completion of the Issuer's merger transaction with Madrigal Pharmaceuticals, Inc. on July 22, 2016.
- F2Reflects a 1-for-35 reverse stock split that was effected by the Issuer on July 22, 2016.
- F3Shares withheld by the Registrant to satisfy minimum statutory withholding requirements upon vesting of RSUs. Withheld shares were not sold.